Browse Drug Recalls

8 FDA drug safety recalls.

FDA Drug Recall Enforcement Database

Browse 8 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.

Drug Safety Recalls

Browse 8 FDA drug recalls.

Clear
DateProductReasonClassFirm
May 20, 2024 Cathflo activase (ALTEPLASE), 2mg vials, Rx only, Genentech Inc., South San F... Lack of Assurance of Sterility: Deformed stoppers observed during filling operations for Cathflo ... Class II Genentech, Inc.
Oct 18, 2022 Susvimo (ranibizumab injection), 100mg/mL, sold together as a) carton contain... Defective Delivery System: Commercial implants do not meet the filed specification for the intend... Class III Genentech Inc
Jun 9, 2021 Xolair (omalizumab) Injection, 150 mg/1 mL, 1 prefilled syringe, Rx Only, For... Failed Stability Specifications: Out of Specification results of Polysorbate 20 (PS20) content we... Class II Genentech Inc
Apr 20, 2021 Evrysdi (risdiplam) for oral solution, 60 mg/80mL (0.75mg/mL), 80 mL total vo... Defective Container: complaints received regarding some incorrect press-in-bottle-adapters (PIBA)... Class III Genentech Inc
Mar 13, 2017 Cotellic (cobimetinib) Tablets, 20 mg, 63 count bottle, Rx Only, Made in Swit... Superpotent Drug: An oversized tablet was found in a bottle. Class II Genentech Inc.
Sep 20, 2012 Nutropin AQ NuSpin 10 (somatropin (rDNA origin) injection} 10 mg/ 2mL Genente... Miscalibrated and/or Defective Delivery System: Genentech has received complaints for Nutropin A... Class II Genentech Inc
Sep 20, 2012 Nutropin AQ NuSpin 20 (somatropin (rDNA origin) injection} 20 mg/ 2mL Genente... Miscalibrated and/or Defective Delivery System: Genentech has received complaints for Nutropin A... Class II Genentech Inc
Jul 30, 2012 Trastuzumab Kit containing 1 vial Trastuzumab (nominal content: 440 mg); 1 20... Presence of Particulate Matter: One lot of Bacteriostatic Water for Injection, USP diluent vials ... Class I Genentech Inc

Frequently Asked Questions

When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.

The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.

Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.